Levothyroxine/Liothyronine Combination Therapy and Quality of Life: Is It All about Weight Loss?

about

Levothyroxine/Liothyronine Combination Therapy and Quality of Life: Is It All about Weight Loss?

Item

http://www.wikidata.org/entity/Q58124610

description

scientific article published on 13 July 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Levothyroxine/Liothyronine Com ...... : Is It All about Weight Loss?

@en

Levothyroxine/Liothyronine Com ...... : Is It All about Weight Loss?

@nl

type

Item

label

Levothyroxine/Liothyronine Com ...... : Is It All about Weight Loss?

@en

Levothyroxine/Liothyronine Com ...... : Is It All about Weight Loss?

@nl

prefLabel

Levothyroxine/Liothyronine Com ...... : Is It All about Weight Loss?

@en

Levothyroxine/Liothyronine Com ...... : Is It All about Weight Loss?

@nl

P1476

Levothyroxine/Liothyronine Com ...... : Is It All about Weight Loss?

@en

P2093

Bjarke Borregaard Medici

http://www.w3.org/2001/XMLSchema#string

Jens Faber

http://www.w3.org/2001/XMLSchema#string

Jeppe Lerche la Cour

http://www.w3.org/2001/XMLSchema#string

Luba Freja Michaelsson

http://www.w3.org/2001/XMLSchema#string

Torquil Watt

http://www.w3.org/2001/XMLSchema#string

P2860

2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism

The powerful placebo.

Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.

Disease-Specific as Well as Generic Quality of Life Is Widely Impacted in Autoimmune Hypothyroidism and Improves during the First Six Months of Levothyroxine Therapy.

Quality of life in patients with benign nontoxic goiter: impact of disease and treatment response, and comparison with the general population.

Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.

High Level of Agreement between Electronic and Paper Mode of Administration of a Thyroid-Specific Patient-Reported Outcome, ThyPRO.

Development of a Short Version of the Thyroid-Related Patient-Reported Outcome ThyPRO.

Treating Hypothyroidism with Thyroxine/Triiodothyronine Combination Therapy in Denmark: Following Guidelines or Following Trends?

Cognitive performance, symptoms and counter-regulation during hypoglycaemia in patients with type 1 diabetes and high or low renin-angiotensin system activity.

P304

243-250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000490383

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Birte Nygaard

P577

2018-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30374427

http://www.w3.org/2001/XMLSchema#string

P932

6198786

http://www.w3.org/2001/XMLSchema#string